Amylyx Pharmaceuticals to Participate at the 6th Annual Evercore ISI HealthCONx Conference
21 Novembro 2023 - 11:00AM
Business Wire
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the
“Company”) today announced that Joshua Cohen and Justin Klee,
Co-CEOs of Amylyx, will participate in the 6th Annual Evercore ISI
HealthCONx Conference. The conference is being conducted in-person
in Miami, Florida and the fireside chat will take place on Tuesday,
November 28, 2023, at 2:10pm ET.
A live webcast of the presentation can be accessed under “Events
and Presentations” in the Investor section of the Company’s
website, https://investors.amylyx.com/news-events/events, and will
be available for replay for 90 days following the event.
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is committed to supporting and
creating more moments for the neurodegenerative disease community
through the discovery and development of innovative new treatments.
Amylyx is headquartered in Cambridge, Massachusetts and has
operations in Canada and EMEA. For more information, visit
amylyx.com and follow us on LinkedIn and X, formerly known as
Twitter. For investors, please visit investors.amylyx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231121828203/en/
Media Amylyx Media Team +1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors Lindsey Allen Amylyx Pharmaceuticals, Inc. +1
(857) 320-6244 Investors@amylyx.com
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024